Home » Stocks » TELA

TELA Bio, Inc. (TELA)

Stock Price: $15.16 USD -0.60 (-3.81%)
Updated Oct 30, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 218.52M
Revenue (ttm) 16.07M
Net Income (ttm) -27.50M
Shares Out 14.41M
EPS (ttm) -3.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $15.16
Previous Close $15.76
Change ($) -0.60
Change (%) -3.81%
Day's Open 15.49
Day's Range 14.92 - 15.49
Day's Volume 15,932
52-Week Range 5.25 - 23.55

More Stats

Market Cap 218.52M
Enterprise Value 163.57M
Earnings Date (est) Nov 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 14.41M
Float 9.14M
EPS (basic) 35.78
EPS (diluted) -3.75
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 172,472
Short Ratio 3.76
Short % of Float 1.89%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 13.60
PB Ratio 3.62
Revenue 16.07M
Operating Income -21.35M
Net Income -27.50M
Free Cash Flow n/a
Net Cash 54.95M
Net Cash / Share 3.81
Gross Margin 59.59%
Operating Margin -132.84%
Profit Margin -171.10%
FCF Margin n/a
ROA -21.49%
ROE -96.61%
ROIC -54.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

(30.28% upside)
Current: $15.16
Target: 19.75
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth86.68%94.91%-
Gross Profit9.272.942.53
Operating Income-19.16-17.78-16.92
Net Income-22.43-21.09-21.33
Shares Outstanding1.770.290.29
Earnings Per Share-17.10-101.41-93.26
Operating Cash Flow-25.52-19.92-16.37
Capital Expenditures-0.20-0.06-0.10
Free Cash Flow-25.72-19.98-16.47
Cash & Equivalents54.5917.2811.37
Total Debt30.2429.734.52
Net Cash / Debt24.34-12.466.86
Book Value30.96-138-108
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name TELA Bio, Inc.
Country United States
Employees 89
CEO Antony Koblish

Stock Information

Ticker Symbol TELA
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: TELA
IPO Date November 8, 2019


TELA Bio, a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.